Palvella Therapeutics, Pieris Pharmaceuticals Announce Definitive Merger Agreement, Concurrent $78.9M Private Financing
July 26, 2024
July 26, 2024
PALO ALTO, California, July 26 -- Cooley, a law firm, issued the following news release:
San Francisco - July 24, 2024 - Cooley advised TD Cowen and Cantor, the placement agents on Palvella Therapeutics' definitive merger agreement with Pieris Pharmaceuticals and concurrent oversubscribed $78.9 million private financing.
BVF Partners, an existing investor, and Frazier Life Sciences, a new investor, co-led the private financing. Palvella and Pieris expect the proposed me . . .
San Francisco - July 24, 2024 - Cooley advised TD Cowen and Cantor, the placement agents on Palvella Therapeutics' definitive merger agreement with Pieris Pharmaceuticals and concurrent oversubscribed $78.9 million private financing.
BVF Partners, an existing investor, and Frazier Life Sciences, a new investor, co-led the private financing. Palvella and Pieris expect the proposed me . . .